First-in-human study of 177Lu-EB-PSMA-617 in patients with metastatic castration-resistant prostate...
First-in-human study of 177Lu-EB-PSMA-617 in patients with metastatic castration-resistant prostate cancer
About this item
Full title
Author / Creator
Zang, Jie , Fan, Xinrong , Wang, Hao , Liu, Qingxing , Wang, Jingnan , Li, Hui , Li, Fang , Jacobson, Orit , Niu, Gang , Zhu, Zhaohui and Chen, Xiaoyuan
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Purpose
This translational study is designed to assess the safety, dosimetry and therapeutic response to a single, low-dose of
177
Lu-EB-PSMA-617 in comparison to
177
Lu-PSMA-617 in patients with mCRPC.
Methods
Following institutional review board approval and informed consent, nine patients with mCRPC were recruited. Four pati...
Alternative Titles
Full title
First-in-human study of 177Lu-EB-PSMA-617 in patients with metastatic castration-resistant prostate cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6250576
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6250576
Other Identifiers
ISSN
1619-7070
E-ISSN
1619-7089
DOI
10.1007/s00259-018-4096-y
